Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Current Issue

June 2025

Paging Dr. Well-Being

Chief wellness officers address systemic pain points in the workplace in an effort to prevent burnout among health care workers.


 

Viewpoints

Editor’s Corner

Pushing Forward With Hematology Clinical and Research Efforts in Chaotic, Uncertain Times

Letter to the Editor

Practical Solutions to Promoting Scholarly Output in Hematology Amid Cuts to Federally Funded Research

Education

You Make the Call

You Make the Call: How would you diagnose and treat a patient presenting with profound thrombocytopenia and signs of an MPN?

You Make the Call: Reader's Response

How would you diagnose and treat a patient presenting with profound thrombocytopenia and signs of an MPN?

Spotlight

Feature Articles

Paging Dr. Well-Being

pASHions

Finding His Rhythm on the Water: Rainer Storb, MD

Pulling Back the Curtain

Pulling Back the Curtain: Clement D. Okello, MMed, MBChB

The Search for Research

A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (NCT04901936)

News

In a Different Vein: News from the Blood Journals

Analysis Identifies Best MRD Endpoint for Predicting Outcomes in NDMM
Magrolimab Plus Azacitidine Did Not Improve Outcomes in TP53-Mutated AML
Cyclophosphamide May Mitigate Movement, Neurocognitive Treatment-Emergent Adverse Events Following Cilta-Cel for R/R MM
Itacitinib Prophylaxis Reduces the Incidence of CRS, ICANS in IEC Therapy

Literature Scan

Analysis Offers Insight Into CAR-T-Related Secondary Malignancies
Large Study Clarifies Risk of Thrombosis Associated With Protein S Deficiency
Combination Pelabresib-Ruxolitinib Shows Disease Burden Benefit in Patients With Myelofibrosis

PDUFA Pending

Odronextamab Back In Front of FDA for Approval
Linvoseltamab Looks to Join Armamentarium of Other Bispecifics for R/R MM
Belantamab Mafodotin Best Used in Combination With Other Regimens
ITP in Children Could Be Added Indication for Avatrombopag
Glofitamab Plus GemOx Combination ‘Completely Practice Changing'

ASH Directions

ASH Education Brings Microlearning to Hematologists’ Screens
ASH Kicks Off Hematology Review Series

The Society Pages

Remembering Dao-Pei Lu (1931 – 2025)

Data Stream

June 2025 Data Stream

Online Only

The Search for Research

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) (NCT06619561)

Literature Scan

24-Hour Urine-Based Response Test Not Necessary for MM
Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM

 

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals